Production and Metabolism of Serotonin (5-HT) by the Human Adrenal Cortex: Paracrine Stimulation of Aldosterone Secretion by 5-HT
Herve Lefebvre,
Patricia Compagnon,
Vincent Contesse,
Catherine Delarue,
Christian Thuillez,
Hubert Vaudry and
Jean-Marc Kuhn
European Institute for Peptide Research (IFRMP 23),
Department of Endocrinology, INSERM U413, University Hospital of Rouen,
(H.L., J.M.K.) 76031 Rouen, France; Laboratory of Cellular and
Molecular Neuroendocrinology, INSERM U413, Unite Associée Centre
National de la Recherche Scientifique, University of Rouen, (H.L.,
V.C., C.D., H.V., J.M.K.) 76821 Mont-Saint-Aignan, France; and
Department of Pharmacology, INSERM E 9920, University Hospital of
Rouen, (P.C., C.T.) 76031 Rouen, France
Address all correspondence and requests for reprints to: Dr. Hervé Lefebvre, IFRMP 23, Department of Endocrinology, INSERM U413, Hospital of Boisguillaume, University Hospital of Rouen, 76031 Rouen cedex, France. E-mail: herve.lefebvre{at}chu-rouen.fr
Abstract
In the human adrenal cortex, serotonin (5-HT) is contained in
mast-likecells, and we have shown that 5-HT stimulates aldosterone
secretion,suggesting that 5-HT may control glomerulosa cells through a
paracrinemechanism. Concurrently, the presence of 5-hydroxyindolacetic
acidin human adrenocortical extracts indicates that 5-HT may be
metabolizedafter local release by mast cells. The aim of the present
studywas to investigate in vitro the production and
metabolism of5-HT by the human adrenal cortex. Perifused adrenal
slices releasedspontaneously detectable amounts of 5-HT (0.74 ±
0.38fmol/mg wet tissue·min). The mast cell-depleting drugcompound
48/80 induced a burst of 5-HT secretion followed bya gradual increase
in aldosterone production. Administrationof the specific
5-HT4 receptor antagonist GR 113808 (10-6
M)did not affect compound 48/80-induced 5-HT release but
abolishedthe stimulatory effect of compound 48/80 on aldosterone
secretion,indicating that 5-HT released locally is responsible for a
paracrinecontrol of steroidogenesis.
Incubation of cells from the human adrenal cortex with 5-HT
(10-5M) provoked the formation of the 5-HT
metabolite 5-hydroxytryptophol.The type A monoamine oxidase (MAO)
inhibitor clorgyline (10-6M) suppressed the
metabolism of 5-HT into 5-hydroxytryptophol.Immunocytochemical
staining of cultured cells revealed the presenceof a subpopulation of
MAO-A-positive cells. Double labelingwith an antiserum against
chromogranin A showed that MAO-A wasactually contained in chromaffin
cells. Similarly, immunohistochemicalstaining of adrenal slices showed
that MAO-A was expressed inchromaffin cells located both in the
medulla and in intracorticalrays.
In conclusion, the present study shows that, in the human adrenal
cortex,5-HT, released by mast-cells, may stimulate aldosterone
secretionin a paracrine manner. Our data also indicate that 5-HT is
metabolizedby MAO-A located in intracortical chromaffin cells.
This article has been cited by other articles:
E Louiset, K Isvi, J M Gasc, C Duparc, B Cauliez, A Laquerriere, J M Kuhn, and H Lefebvre Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol
Endocr. Relat. Cancer,
December 1, 2008;
15(4):
1025 - 1034.
[Abstract][Full Text][PDF]
D. Cartier, S. Jegou, F. Parmentier, I. Lihrmann, E. Louiset, J.-M. Kuhn, C. Bastard, P.-F. Plouin, M. Godin, H. Vaudry, et al. Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas
Eur. J. Endocrinol.,
December 1, 2005;
153(6):
939 - 947.
[Abstract][Full Text][PDF]
V. Contesse, Y. Reznik, E. Louiset, C. Duparc, D. Cartier, F. Sicard, A. Laquerriere, F. Parmentier, J.-M. Kuhn, H. Vaudry, et al. Abnormal Sensitivity of Cortisol-Producing Adrenocortical Adenomas to Serotonin: In Vivo and in Vitro Studies
J. Clin. Endocrinol. Metab.,
May 1, 2005;
90(5):
2843 - 2850.
[Abstract][Full Text][PDF]
J. Bertherat, V. Contesse, E. Louiset, G. Barrande, C. Duparc, L. Groussin, P. Emy, X. Bertagna, J.-M. Kuhn, H. Vaudry, et al. In Vivo and in Vitro Screening for Illegitimate Receptors in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Causing Cushing's Syndrome: Identification of Two Cases of Gonadotropin/Gastric Inhibitory Polypeptide-Dependent Hypercortisolism
J. Clin. Endocrinol. Metab.,
March 1, 2005;
90(3):
1302 - 1310.
[Abstract][Full Text][PDF]
A. Slominski, J. Wortsman, and D. J. Tobin The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
FASEB J,
February 1, 2005;
19(2):
176 - 194.
[Abstract][Full Text][PDF]
M. Mannelli, P. Ferruzzi, P. Luciani, C. Crescioli, L. Buci, G. Corona, M. Serio, and A. Peri Cushing's Syndrome in a Patient with Bilateral Macronodular Adrenal Hyperplasia Responding to Cisapride: An in Vivo and in Vitro Study
J. Clin. Endocrinol. Metab.,
October 1, 2003;
88(10):
4616 - 4622.
[Abstract][Full Text][PDF]
R. A. Feelders, S. W. J. Lamberts, L. J. Hofland, P. M. van Koetsveld, M. Verhoef-Post, A. P. N. Themmen, F. H. de Jong, H. J. Bonjer, A. J. Clark, A.-J. van der Lely, et al. Luteinizing Hormone (LH)-Responsive Cushing's Syndrome: The Demonstration of LH Receptor Messenger Ribonucleic Acid in Hyperplastic Adrenal Cells, which Respond to Chorionic Gonadotropin and Serotonin Agonists in Vitro
J. Clin. Endocrinol. Metab.,
January 1, 2003;
88(1):
230 - 237.
[Abstract][Full Text][PDF]
H. Lefebvre, D. Cartier, C. Duparc, I. Lihrmann, V. Contesse, C. Delarue, M. Godin, R. Fischmeister, H. Vaudry, and J.-M. Kuhn Characterization of Serotonin4 Receptors in Adrenocortical Aldosterone-Producing Adenomas: In Vivo and in Vitro Studies
J. Clin. Endocrinol. Metab.,
March 1, 2002;
87(3):
1211 - 1216.
[Abstract][Full Text][PDF]